Skip to main content
Equibles

Opaleye Management Inc.

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1595855 Boston, MA
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,851,381
+$3,545,766 QoQ
Shares Held
1,412,656
0.0% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#9
of 114 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. ZNTL ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IRON
Disc Medicine, Inc.
 855,000 $62,534,700
2 URGN
UroGen Pharma Ltd.
 1,439,996 $52,991,852
3
390,000 $51,764,700
4 MGTX
MeiraGTx Holdings plc
 3,550,000 $47,960,500
5 SLGL
Sol-Gel Technologies Ltd.
 500,000 $37,070,000
6 RZLT
Rezolute, Inc.
 6,300,000 $32,760,000
7 TGTX
Tg Therapeutics, Inc.
 535,000 $29,392,900
8 IMMX
Immix Biopharma, Inc.
 2,345,000 $24,176,950

All Filings in ZNTL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,851,381 1,412,656
2026-03-31 $3,305,615 1,412,656
2025-12-31 $1,891,223 1,400,906
2025-09-30 $477,990 316,550
2025-06-30 $2,232,188 1,924,300
2025-03-31 $3,156,150 1,985,000
2024-12-31 $5,355,525 1,767,500
2024-09-30 $3,558,560 967,000
2024-03-31 $3,152,000 200,000
2022-12-31 $3,373,450 167,500